Synthesis, in vitro, and in vivo activity of N-p-substituted-benzyl- (- )- and (+)-N-normetazocines, (-)- and (+)-N-normorphinans, N- norketobemidones, and (-)-N-nor-4,5-epoxymorphinans

Medicinal Chemistry Research

Volumn 8, Issue 6, 1998, Pages 311-321

  May, Everette L ^c   Jacobson, Arthur E ^a   Mattson, Mariena V ^a   Coop, Andrew ^a   Aceto, Mario D ^c   Bowman, Edward R ^c   Traynor, John R ^b   Woods, James H ^b   Harris, Louis S ^c  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

KETOBEMIDONE; LEVORPHANOL; MORPHINAN DERIVATIVE; MORPHINE SULFATE; N ALLYLNORMETAZOCINE; N BENZYL N NORMETAZOCINE; N BENZYLNOROXYMORPHONE; N NOR 4,5 EPOXYMORPHINAN DERIVATIVE; N NORKETOBEMIDONE DERIVATIVE; N NORMORPHINAN DERIVATIVE; NALOXONE; NORMETAZOCINE DERIVATIVE; PENTAZOCINE; SIGMA OPIATE RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTINOCICEPTION; ARTICLE; DOSE RESPONSE; DRUG RECEPTOR BINDING; DRUG STRUCTURE; DRUG SYNTHESIS; MALE; MONKEY; NONHUMAN; RAT; RECEPTOR AFFINITY; SUBCUTANEOUS DRUG ADMINISTRATION; TAIL FLICK TEST;

EID: 0032417920     PISSN: 10542523     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. May, E.L.; Aceto, M.D.; Bowman, E.R.; Bentley, C.; Martin, B.R.; Harris, L.S.; Medzihradsky, F.; Mattson, M.V.; Jacobson, A.E. J. Med. Chem. 1994, 37, 3408-3418.
2. Quirion, R.; Bowen, W.D.; Itzhak, Y.; Junien, J.L.; Musacchio, J.M.; Rothman, R.B.; Su, T.P.; Tam, S.W.; Taylor, D.P. Trends Pharmacol. Sci. 1992, 13, 85-86.
3. Quirion, R.; Chicheportiche, R.; Contreras, P.C.; Johnson, K.M.; Lodge, D.; Tam, S.W.; Woods, J.H.; Zukin, S.R. Trends Neurosci. 1987, 10, 444-446.
4. Bowen, W.D.; Vilner, B.J.; Lee, K.S.; He, X.-S.; de Costa, B.R.; Weinberger, D.R. Soc. Neuorsci. Abstr. 1995, 21, 219.5, 526.
5. Walker, J.M.; Bowen, W.D.; Walker, F.O.; Matsumoto, R.R.; de Costa, B.; Rice, K.C. Pharmacol. Rev. 1990, 42, 355-402.
6. Rothman, R.B.; Reid, A.; Mahboubi, A.; Kim, C.H.; de Costa, B.R.; Jacobson, A.E.; Rice, K.C. Mol. Pharmacol. 1991, 39, 222-232.
7. Bowen, W.D.; Walker, J.M.; Yashar, A.G.; Matsumoto, R.R.; Walker, F.O.; Lorden, J.F. Eur. J. Pharmacol. 1988, 147, 153-154.
8. Goldstein, S.R.; Matsumoto, R.R.; Thompson, T.L.; Patrick, R.L.; Bowen, W.D.; Walker, J.M. Synapse 1989, 4, 254-258.
9. Matsumoto, R.R.; Hemstreet, M.K.; Lai, N.L.; Thurkauf, A.; de Costa, B.R.; Rice, K.C.; Hellewell, S.B.; Bowen, W.D.; Walker, J.M. Pharmacol. Biochem. Behav. 1990, 36, 151-155.
10. Walker, J.M.; Matsumoto, R.R.; Bowen, W.D.; Gans, D.L.; Jones, K.D.; Walker, F.O. Neurology 1988, 38, 961-965.
11. Campbell, B.G.; Bobker, D.H.; Leslie, F.M.; Mefford, I.N.; Weber, E. Eur. J. Pharmacol. 1987, 138, 447-449.
12. Campbell, B.G.; Scherz, M.W.; Keana, J.F.; Weber, E. J. Neurosci. 1989, 9, 3380-3391.
13. Vaupel, D.B.; Su, T.P. Eur. J. Pharmacol. 1987, 139, 125-128.
14. Bowen, W.D.; Tolentino, P.J.; Kirschner, B.N.; Varghese, P.; de Costa, B.R.; Rice, K.C. In Sigma, PCP, and NMDA Receptors; DeSouza, E.B., Clouet, D.H., London, E.D., Eds.; NIDA Monograph 133: Washington, D.C., 1993, p 69-93.
15. Bowen, W.D.; Kirschner, B.N.; Newman, A.H.; Rice, K.C. Eur. J. Pharmacol. 1988, 149, 399-400.
16. Ceci, A.; Smith, M.; French, E.D. Eur. J. Pharmacol. 1988, 154, 53-57.
17. Matsumoto, R.R.; Walker, J.M. Eur. J. Pharmacol. 1988, 158, 161-165.
18. Bowen, W.D.; Hellewell, S.B.; McGarry, K.A. Eur. J. Pharmacol. 1989, 163, 309-318.
19. Bowen, W.D.; de Costa, B.R.; Hellewell, S.B.; Walker, M.; Rice, K.C. Molec. Neuropharmacol. 1993, 3, 117-126.
20. Hellewell, S.B.; Bowen, W.D. Brain Res. 1990, 527, 244-253.
21. Carroll, F.I.; Abraham, P.; Parham, K.; Bai, X.; Zhang, X.; Brine, G.A.; Mascarella, S.W.; Martin, B.R.; May, E.L.; Sauss, C.; Dipaolo, L.; Wallace, P.; Walker, J.M.; Bowen, W.D. J. Med. Chem. 1992, 35, 2812-2818.
22. Teramura, T.; Tokunaga, T.; Matsumoto, H.; Watanabe, T.; Higuchi, S. Xenobiotica 1996, 26, 177-187.
23. Portoghese, P.S.; Sultana, M.; Nagase, H.; Takemori, A.E. J. Med. Chem. 1988, 31, 281-282.
24. Footnote, .
25. Bohm, H.-J.; Klebe, G. Angew. Chem. Int. Ed. Eng. 1996, 35, 2588-2614.
26. D'Amour, F.E.; Smith, D.L. J. Pharmacol. Exp. Ther. 1941, 72, 74-79.
27. Dewey, W.L.; Harris, L.S. J. Pharmacol. Exp. Ther. 1971, 179, 652-659.
28. Pearl, J.; Harris, L.S. J. Pharmacol. Exp. Ther. 1966, 154, 319-323.
29. Eddy, N.B.; Leimbach, D. J. Pharmacol. Exp. Ther. 1953, 107, 385-393.
30. Jacobson, A.E.; May, E.L. J. Med. Chem. 1965, 8, 563-566.
31. Aceto, M.D.; Bowman, E.R.; Harris, L.S.; May, E.L. In Problems of Drug Dependence 1996; Harris, L.S., Ed.; NIDA Research Monograph 174: Washington, D.C., 1997, p 338-395.
32. Hellewell, S.B.; Bruce, A.; Feinstein, G.; Orringer, J.; Williams, W.; Bowen, W.D. Eur. J. Pharmacol.-Molec Pharm 1994, 268, 9-18.
33. Cheng, Y.-C.; Prusoff, W.H. Biochem. Pharmacol. 1973, 22, 3099-3103.
34. Emmerson, P.J.; Liu, M.R.; Woods, J.H.; Medzihradsky, F. J Pharmacol Exp Ther 1994, 271, 1630-1637.
35. Schnider, O.; Grüssner, A. Helvetica Chimica Acta 1951, 34, 2211-2217.